Table 1.
Insulin Initiation | OAA Initiation | p-value | |
---|---|---|---|
N | 18%(n=88) | 82% (n=401) | - |
Sex | |||
Male | 52.3% (n=46) | 42.7% (n=171) | 0.1 |
Female | 47.7% (n=42) | 57.3% (n=230) | |
Race/Ethnicity | |||
AAB/non-Hispanic Black | 35.2% (n=31) | 17.5% (n=70) | 0.001 |
Caucasian/Other | 10.2% (n=9) | 14.2% (n=58) | |
Hispanic | 54.6% (n=48) | 68.3% (n=273) | |
Age (years) (SD) | 47.1 (±10.3) | 48.6 (±11.2) | 0.273 |
Comorbidities | |||
Hypertension | 69.3% (n=61) | 59.9% (n=240) | 0.98 |
Hyperlipidemia | 78.4% (n=69) | 76.6% (n=307) | 0.709 |
Diabetes Sequelae | 11.2% (n=10) | 8.9% (n=36) | 0.265 |
Coronary artery disease | 4.5% (n=4) | 4.7% (n=19) | |
Congestive heart failure | 4.5% (n=4) | 1.5% (n=6) | |
Chronic kidney disease | 1.1% (n=1) | 0.7% (n=3) | |
Cerebral vascular attack | 1.1% (n=1) | 2.0% (n=8) |
OAs: Oral Hypoglycemic Agents;
AA: African American;
ED: Emergency Department